Peptide modulation of inflammatory processes within the brain

NeuroImmunoModulation

Volumn 5, Issue 3-4, 1998, Pages 178-183

  Lipton, James M ^a,c   Catania, Anna ^b   Delgado, René ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

MSH; Astrocyte; Brain; Inflammation; Melanocortin receptors; Melanocortins; Microglia; Nitric oxide; TNF

Indexed keywords

ALPHA INTERMEDIN; CYTOKINE; MELANOCORTIN RECEPTOR; NEUROPEPTIDE; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

BRAIN ISCHEMIA; ENCEPHALITIS; EVOKED AUDITORY RESPONSE; HUMAN; IMMUNOMODULATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW;

ALPHA-MSH; ANIMALS; BRAIN; HUMANS; NEUROIMMUNOMODULATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031671209     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026335     Document Type: Review

References (50)

1. Lassmann H: Basic mechanisms of brain inflammation. J Neural Trans Suppl 1997;50: 183-190.
2. Raine CS: The Dale E. McFarlin Memorial Lecture: The immunology of the multiple sclerosis lesion. Ann Neurol 1994;36(suppl):61-72.
3. Woodroofe MN, Cuzner ML: Cytokine expression in inflammatory multiple sclerosis lesions: Detection by non-radioactive in situ hybridization. Cytokine 1993; 5:583-588.
4. Selmaj KW, Raine CS: Experimental autoimmune encephalomyelitis: Immunotherapy with anti-tumor necrosis factor antibodies and soluble tumor necrosis factor receptors. Neurology 1995;45:S44-S49.
5. Koka P, He K, Camerini D, Tran T, Yashar SS, Merrill JE: The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor α production in glial cells. J Neuroimmunol 1995;57:179-191.
6. Tyor WR, Wesselingh SL, Griffin JW, McArthur JC, Griffin DE: Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathology. J Acquir Immune Defic Syndr Hum Retrovirol 1995;9:379-388.
7. Yeung MC, Pulliam L, Lau AS: The HIV envelope protein gp120 is toxic to human brain-cell cultures through the induction of interleukin-6 and tumor necrosis factor-alpha. AIDS 1995;9: 137-143.
8. Merrill JE, Koyanagi Y, Zack J, Thomas L, Martin F, Chen IS: Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type I. J Virol 1992;66:2217-2225.
9. Meda L, Cassatella MA, Szendrei GI, Otvos L Jr, Baron P, Villalba M, Ferrari D, Rossi F: Activation of microglial cells by beta-amyloid protein and interferon gamma. Nature 1995; 374:647-650.
10. Glimaker M, Kragsbjerg P, Forsgren M, Olcen P: Tumor necrosis factor-alpha (TNF alpha) in cerebrospinal fluid from patients with meningitis of different etiologies: High levels of TNF alpha indicate bacterial meningitis. J Infect Dis 1993;167:882-889.
11. Dulderian SJ, Kilpatrick L, Costarino AT Jr, McCawley L, Fein J, Corcoran L, Zirin S, Harris MC: Cytokine elevations in infants with bacterial and aseptic meningitis. J Pediatr 1995;125:872-876.
12. Kimberlin DW, Velasco S, Paris MM, Hickey SM, McCracken GH Jr, Nisen PD: Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells. Immunol Invest 1995;24:775-785.
13. Tarlow MJ, Jenkins R, Comis SD, Osborne MP, Stephens S, Stanley P, Crocker J: Ependymal cells of the choroid plexus express tumor necrosis factor-alpha. Neuropathol Appl Neurobiol 1993;19:324-328.
14. Feuerstein GZ, Liu T, Barone FC: Cytokines, inflammation, and brain injury: Role of tumor necrosis factora-alpha. Cerebrovasc Brain Metab Rev 1994;6:341-360.
15. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ: The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg 1994;8:419-425.
16. Lipton JM, Catania A: AP Mechanisms of antiinflammatory action of the neuroimmunomodulatory peptide α-MSH. Ann NY Acad Sci, in press.
17. Lipton JM, Catania A: Antiinflammatory influence of the neuroimmunomodulator α-MSH. Immunol Today 1997;18:140-145.
18. Lipton JM, Catania A: α-Melanocyte stimulating hormone in the modulation of host reactions. Endocr Rev 1993;14:564-576.
19. Rajora N, Boccoli G, Burns D, Sharma S, Catania AP, Lipton JM: α-MSH modulates local and circulating TNFα in experimental brain inflammation. J Neuroscience 1997;17: 2181-2186.
20. Wilson JF: Low permeability of the blood-brain barrier to nanomolar concentrations of immunoreactive α-melanotropin. Psychopharmacology 1988;96:262-266.
21. Perry VH, Gordon S: Macrophages and microglia in the nervous system. Trends Neurosci 1988;11:273-277.
22. Perry VH, Hume DA, Gordon S: Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience 1992;15:313-326.
23. Star RA, Rajora N, Huang J, Chavez R, Catania A, Lipton JM: Evidence of autocrine modulation of macrophage nitric oxide synthase by α-MSH. Proc Natl Acad Sci USA 1995;92: 8016-8020.
24. Rajora N, Ceriani G, Catania A, Star RA, Murphy MT, Lipton JM: α-MSH production, receptors, and influence on neopterin, in a human monocyte/macrophage cell line. J Leukocyte Biol 1996;59:248-253.
25. Wong KY, Rajora N, Boccoli G, Catania A, Lipton JM: A potential mechanism of local antiinflammatory action of α-MSH peptides within the brain: Modulation of TNFα production by human astrocytic cells. Neuroimmunomodulation 1997;4:37-41.
26. Huh S-K, Lipton JM, Batjer HH: The protective effects of α-melanocyte stimulating hormone on canine brainstem ischemia. J Neurosurg 1997;40:132-139.
27. Airaghi L, Lettino M, Manfredi MG, Lipton JM, Catania A: Endogenous cytokine antagonists during myocardial ischemia and thrombolytic therapy. Am Heart J 1995;130:204-211.
28. Catania A, Rajora N, Capsoni F, Minonzio F, Star RA, Lipton JM: The neuropeptide a-msh has specific receptors on neutrophils and reduces chemotaxis in vitro. Peptides 1996;17: 675-679.
29. Mason MJ, Van Epps D: Modulation of IL-1, tumor necrosis factor, and C5α-mediated murine neutrophil migration by α-melanocyte-stimulating hormone. J Immunol 1989;142: 1646-1651.
30. Popovich PG, Wei P, Stokes BT: Cellular inflammatory response after spinal cord injury in Sprague-Dawley and Lewis rats. J Comp Neurol 1997;377:443-464.
31. Matsuo Y, Kihara T, Ikeda M, Ninomiya M, Onodera H, Kogure K: Role of neutrophils in radical production during ischemia and reperfusion of the rat brain: Effect of neutrophil depletion on extracellular ascorbyl radical formation. J Cereb Blood Flow Metab 1995;15: 941-947.
32. Hudome S, Palmer C, Roberts RL, Mauger D, Housman C, Towfighi J: The role of neutrophils in the production of hypoxic-ischemic brain injury in the neonatal rat. Pediatr Res 1997;41:607-616.
33. Chiao H, Foster S, Thomas R, Lipton J, Star RA: Alpha-melanocyte stimulating hormone reduces endotoxin-induced liver inflammation. J Clin Invest 1996;97:2038-2044.
34. Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA: Alpha-Melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 1997; 99:1165-1172.
35. Kreutzberg GW: Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996;19:312-318.
36. Benveniste EN: Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J Mol Med 1997;75: 165-173.
37. Breitner JC: The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease. Annu Rev Med 1996;47:401-411.
38. Aisen PS: Inflammation and Alzheimer disease. Mol Chem Neuropathol 1996;28:83-88.
39. McGeer PL, McGeer EG: Anti-inflammatory drugs in the fight against Alzheimer's disease. Ann NY Acad Sci 1996;777:213-220.
40. Lieberman AP, Pitha PM, Shin HS, Shin ML: Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci USA 1989;86:6348-6352.
41. Assoglou K, Probert L, Kontogeorgos G, Kollias G: Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J Immunol 1997; 158:438-445.
42. Skaper SD, Facci L, Leon A: Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J Neurochem 1995;64:266-276.
43. Chhajlani, V, Wikberg JES: Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett 1992;309:417-420.
44. Mountjoy KG, Robbins LS, Mortrud MT, Cone RD: The cloning of a family of genes that encode the melanocortin receptors. Science 1992;257:1248-1251.
45. Gantz I, Miwa H, Konda Y, Shimoto Y, Tashiro T, Watson SJ, DelValle J, Yamada T: Molecular cloning, expression and gene localization of a fourth melanocortin receptor. J Biol Chem 1993;268:15174-15179.
46. Gantz I, Shimoto Y, Konda Y, Miwa H, Dickinson CJ, Yamada T: Molecular cloning, expression and characterization of a fifth melanocortin receptor. Biochem Biophys Res Commun 1994;200:1214-1220.
47. Labbe O, Desamaud F, Eggerickx D, Vassart G, Parmentier M: Molecular cloning of a mouse melanocortin 5 receptor gene widely expressed in peripheral tissues. Biochemistry 1994;33:4543-4549.
48. Roselli-Rehfuss L, Mountjoy KG, Robbins LS, Mortrud MT, Low ML, Tatro JB, Entwistle ML, Simerly RB, Cone RD: Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA 1993;90:8856-8860.
49. Tatro JB: Receptor biology of the melanocortins, a family of neuroimmunodulatory peptides. Neuroimmunomodulation 1996;3:259-284.
50. Xia Y, Wikberg JE, Chhajlani V: Expression of melanocortin 1 receptor in periaqueductal gray matter. Neuroreport 1995;6:2193-2196.